Skip to main content
Clinical Trials/NCT05468385
NCT05468385CompletedNot Applicable

Transcutaneous Auricular Vagus Nerve Stimulation Improves Inhibitory Control in Emotional Go-Nogo Task

University of Electronic Science and Technology of China1 site in 1 country90 target enrollmentStarted: May 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
The ability of inhibitory control in an emotional Go-Nogo task

Study Overview

Brief Summary

The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) improves the ability of inhibitory control in an emotional Go-Nogo task.

Detailed Description

A randomized, sham-controlled, between-subject design will be employed in this study. A total of 87 healthy subjects will receive either transcutaneous vagus nerve stimulation via tragus or sham stimulation via the earlobe in the left ear. Brain activity and behavioral data for an emotional Go-Nogo task will be recorded and saliva samples will be collected before, during, and after stimulation.

Some personal traits will be assessed using different kinds of questionnaires, such as the State-Trait Anxiety Inventory (STAI), Beck's Depression Inventory(BDI), Autism Spectrum Quotient (ASQ) et al.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 25 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy subjects without past or current psychiatric or neurological disorders

Exclusion Criteria

  • history of head injury;
  • pregnant, menstruating, taking oral contraceptives;
  • medical or psychiatric illness.

Outcomes

Primary Outcomes

The ability of inhibitory control in an emotional Go-Nogo task

Time Frame: After 30 minutes stimulation

Analysis the behavioral and brain data recorded during the task

Oxytocin release

Time Frame: within 5 minutes after taVNS via tragus and earlobe

Investigating the oxytocin release after taVNS via tragus and earlobe based on saliva samples

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Electronic Science and Technology of China
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Keith Kendrick

Professor

University of Electronic Science and Technology of China

Study Sites (1)

Loading locations...

Similar Trials